TABLE 3.
Variable | Mild/moderate symptoms, n (%) | Severe/critical symptoms, n (%) | OR (95% CI) | aOR a (95% CI) | p‐Value |
---|---|---|---|---|---|
Neg qPCR (Ref) n = 24 | 16 (52) | 8 (28) | 1.0 (Ref) | 1.0 (Ref) | |
C t value >30 n = 21 | 11 (36) | 10 (35) | 1.82 (0.55–6.1) | 4.78 (0.90–25.3) | .066 |
C t value <30 n = 15 | 4 (13) | 11 (38) | 5.50 (1.32–22.9) | 15.30 (1.74–134) | .014 |
Adjusted for remdesivir treatment, body mass index, soluble urokinase plasminogen activator receptor, C‐reactive protein, and neutrophil‐to‐lymphocyte ratio.